Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases (original) (raw)
Doetschman, T. et al. Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature330, 576–578 (1987). ArticleCASPubMed Google Scholar
Thomas, K. R. & Capecchi, M. R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell51, 503–512 (1987). ArticleCASPubMed Google Scholar
Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature292, 154–156 (1981). CASPubMed Google Scholar
The 2007 Nobel Prize in Physiology or Medicine - Press Release. Nobelprize.org[online]
Rouet, P., Smih, F. & Jasin, M. Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol. Cell. Biol.14, 8096–8106 (1994). This study first demonstrated that nuclease-induced DSBs could stimulate homologous recombination. ArticleCASPubMedPubMed Central Google Scholar
Silva, G. et al. Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy. Curr. Gene Ther.11, 11–27 (2011). ArticleCASPubMedPubMed Central Google Scholar
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S. & Gregory, P. D. Genome editing with engineered zinc finger nucleases. Nature11, 636–646 (2010). CAS Google Scholar
Doudna, J. A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science346, 1258096 (2014). ArticleCASPubMed Google Scholar
Kim, Y. G., Cha, J. & Chandrasegaran, S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc. Natl Acad. Sci. USA93, 1156–1160 (1996). ArticleCASPubMedPubMed Central Google Scholar
Cermak, T. et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res.39, e82 (2011). ArticleCASPubMedPubMed Central Google Scholar
Li, T. et al. Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes. Nucleic Acids Res.39, 6315–6325 (2011). ArticleCASPubMedPubMed Central Google Scholar
Bitinaite, J., Wah, D. A., Aggarwal, A. K. & Schildkraut, I. FokI dimerization is required for DNA cleavage. Proc. Natl Acad. Sci. USA95, 10570–10575 (1998). ArticleCASPubMedPubMed Central Google Scholar
Wah, D. A., Bitinaite, J., Schildkraut, I. & Aggarwal, A. K. Structure of FokI has implications for DNA cleavage. Proc. Natl Acad. Sci. USA95, 10564–10569 (1998). ArticleCASPubMedPubMed Central Google Scholar
Boissel, S. et al. megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering. Nucleic Acids Res.42, 2591–2601 (2014). ArticleCASPubMed Google Scholar
Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science337, 816–821 (2012). This was the first published study to demonstrate that the target specificity of Cas9 could be programmed using an engineered single gRNA (a fusion of naturally occurring crRNA and tracrRNA). ArticleCASPubMedPubMed Central Google Scholar
Hou, Z. et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc. Natl Acad. Sci. USA110, 15644–15649 (2013). ArticleCASPubMedPubMed Central Google Scholar
Zhang, X.-H., Tee, L. Y., Wang, X.-G., Huang, Q.-S. & Yang, S.-H. Off-target effects in CRISPR/Cas9-mediated genome engineering. Mol. Ther. Nucleic Acids4, e264 (2015). ArticleCASPubMedPubMed Central Google Scholar
Pattanayak, V., Guilinger, J. P. & Liu, D. R. Determining the specificities of TALENs, Cas9, and other genome-editing enzymes. Methods Enzymol.546, 47–78 (2014). ArticleCASPubMedPubMed Central Google Scholar
LaFountaine, J. S., Fathe, K. & Smyth, H. D. C. Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9. Int. J. Pharm.494, 180–194 (2015). ArticleCASPubMed Google Scholar
Jamal, M. et al. Keeping CRISPR/Cas on-target. Curr. Issues Mol. Biol.20, 1–20 (2015). PubMed Google Scholar
Ishida, K., Gee, P. & Hotta, A. Minimizing off-target mutagenesis risks caused by programmable nucleases. Int. J. Mol. Sci.16, 24751–24771 (2015). ArticleCASPubMedPubMed Central Google Scholar
Bolukbasi, M. F., Gupta, A. & Wolfe, S. A. Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery. Nat. Methods13, 41–50 (2015). ArticleCAS Google Scholar
Yang, H. et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell154, 1370–1379 (2013). ArticleCASPubMedPubMed Central Google Scholar
Cho, S. W. et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res.24, 132–141 (2014). ArticleCASPubMedPubMed Central Google Scholar
Liang, X. et al. Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. J. Biotechnol.208, 44–53 (2015). ArticleCASPubMed Google Scholar
Pattanayak, V. et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol.31, 839–843 (2013). ArticleCASPubMedPubMed Central Google Scholar
Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol.31, 822–826 (2013). This was the first study to report high-frequency off-target CRISPR–Cas9 mutagenesis. ArticleCASPubMedPubMed Central Google Scholar
Cradick, T. J., Fine, E. J., Antico, C. J. & Bao, G. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res.41, 9584–9592 (2013). ArticleCASPubMedPubMed Central Google Scholar
Lin, Y. et al. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res.42, 7473–7485 (2014). ArticleCASPubMedPubMed Central Google Scholar
Zhang, H. et al. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation. Plant Biotechnol. J.12, 797–807 (2014). ArticleCASPubMed Google Scholar
Gasiunas, G., Barrangou, R., Horvath, P. & Siksnys, V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl Acad. Sci. USA109, E2579–E2586 (2012). CASPubMedPubMed Central Google Scholar
Cho, S. W., Kim, S., Kim, J. M. & Kim, J.-S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol.31, 230–232 (2013). ArticleCASPubMed Google Scholar
Heigwer, F., Kerr, G. & Boutros, M. E-CRISP: fast CRISPR target site identification. Nat. Methods11, 122–123 (2014). ArticleCASPubMed Google Scholar
Pattanayak, V., Ramirez, C. L., Joung, J. K. & Liu, D. R. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat. Methods8, 765–770 (2011). ArticleCASPubMedPubMed Central Google Scholar
Guilinger, J. P. et al. Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity. Nat. Methods11, 429–435 (2014). ArticleCASPubMedPubMed Central Google Scholar
Sander, J. D. et al. In silico abstraction of zinc finger nuclease cleavage profiles reveals an expanded landscape of off-target sites. Nucleic Acids Res.41, e181 (2013). ArticleCASPubMedPubMed Central Google Scholar
Smith, C. et al. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell15, 12–13 (2014). ArticleCASPubMedPubMed Central Google Scholar
Veres, A. et al. Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell15, 27–30 (2014). ArticleCASPubMedPubMed Central Google Scholar
Iyer, V. et al. Off-target mutations are rare in Cas9-modified mice. Nat. Methods12, 479–479 (2015). ArticleCASPubMed Google Scholar
Tsai, S. Q. & Joung, J. K. What's changed with genome editing? Cell Stem Cell15, 3–4 (2014). ArticleCASPubMed Google Scholar
Gabriel, R. et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat. Biotechnol.29, 816–823 (2011). This is the first report of an unbiased genome-wide analysis of nuclease specificity, by analysing IDLV capture into ZFN-induced DSBs. ArticleCASPubMed Google Scholar
Osborn, M. J. et al. Evaluation of TCR gene editing achieved by TALENs, CRISPR/Cas9 and megaTAL nucleases. Mol. Ther.24, 570–581 (2016). ArticleCASPubMedPubMed Central Google Scholar
Wang, X. et al. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat. Biotechnol.33, 175–178 (2015). ArticleCASPubMed Google Scholar
Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol.33, 187–197 (2015). This study describes the GUIDE-seq method for identifying Cas9 off-target cleavage sites in living cells. ArticleCASPubMed Google Scholar
Tsai, S. Q., Topkar, V. V., Joung, J. K. & Aryee, M. J. Open-source software guideseq for analysis of GUIDE-seq data. Nat. Biotechnol. (in the press).
Chiarle, R. et al. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell147, 107–119 (2011). ArticleCASPubMedPubMed Central Google Scholar
Frock, R. L. et al. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat. Biotechnol.33, 179–186 (2015). This study describes the HTGTS method for identifying Cas9 off-target cleavage by translocation sequencing. ArticleCASPubMed Google Scholar
Crosetto, N. et al. Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat. Methods10, 361–365 (2013). This is the original study describing the BLESS method, which was later adapted to analyse CRISPR–Cas9 off-target cleavage. ArticleCASPubMedPubMed Central Google Scholar
Kim, D. et al. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat. Methods12, 237–243 (2015). This study describes Digenome-seq, anin vitrogenome-wide method for identifying CRISPR–Cas9 off-target cleavage sites. ArticleCASPubMed Google Scholar
Kim, D., Kim, S., Kim, S., Park, J. & Kim, J.-S. Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq. Genome Res.http://dx.doi.org/10.1101/gr.199588.115 (2016).
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M. & Joung, J. K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol.32, 279–284 (2014). ArticleCASPubMedPubMed Central Google Scholar
Mali, P. et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol.31, 833–838 (2013). ArticleCASPubMedPubMed Central Google Scholar
Guilinger, J. P., Thompson, D. B. & Liu, D. R. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat. Biotechnol.32, 577–582 (2014). ArticleCASPubMedPubMed Central Google Scholar
Wyvekens, N., Topkar, V. V., Khayter, C., Joung, J. K. & Tsai, S. Q. Dimeric CRISPR RNA-guided FokI-dCas9 nucleases directed by truncated gRNAs for highly specific genome editing. Hum. Gene Ther.26, 425–431 (2015). ArticleCASPubMedPubMed Central Google Scholar
Nakagawa, Y. et al. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes. BMC Biotechnol.15, 33 (2015). ArticlePubMedPubMed CentralCAS Google Scholar
Kleinstiver, B. P. et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature529, 490–495 (2016). ArticleCASPubMedPubMed Central Google Scholar
Slaymaker, I. M. et al. Rationally engineered Cas9 nucleases with improved specificity. Science351, 84–88 (2016). ArticleCASPubMed Google Scholar
Anders, C., Niewoehner, O., Duerst, A. & Jinek, M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature513, 569–573 (2014). ArticleCASPubMedPubMed Central Google Scholar
Kim, S., Kim, D., Cho, S. W., Kim, J. & Kim, J. S. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res.24, 1012–1019 (2014). ArticleCASPubMedPubMed Central Google Scholar
Zuris, J. A. et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol.33, 73–80 (2015). ArticleCASPubMed Google Scholar
Gaj, T., Guo, J., Kato, Y., Sirk, S. J. & Barbas, C. F. Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat. Methods9, 805–807 (2012). ArticleCASPubMedPubMed Central Google Scholar
Zetsche, B., Volz, S. E. & Zhang, F. A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat. Biotechnol.33, 139–142 (2015). ArticleCASPubMed Google Scholar
Nihongaki, Y., Kawano, F., Nakajima, T. & Sato, M. Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat. Biotechnol.33, 755–760 (2015). ArticleCASPubMed Google Scholar
Davis, K. M., Pattanayak, V., Thompson, D. B., Zuris, J. A. & Liu, D. R. Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat. Chem. Biol.11, 316–318 (2015). ArticleCASPubMedPubMed Central Google Scholar
Jiang, F., Zhou, K., Ma, L., Gressel, S. & Doudna, J. A. A Cas9-guide RNA complex preorganized for target DNA recognition. Science348, 1477–1481 (2015). ArticleCASPubMed Google Scholar
Knight, S. C. et al. Dynamics of CRISPR-Cas9 genome interrogation in living cells. Science350, 823–826 (2015). ArticleCASPubMed Google Scholar
Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C. & Doudna, J. A. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature507, 62–67 (2014). ArticleCASPubMedPubMed Central Google Scholar
Kleinstiver, B. P. et al. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat. Biotechnol.33, 1293–1298 (2015). ArticleCASPubMedPubMed Central Google Scholar
Bolukbasi, M. F. et al. DNA-binding-domain fusions enhance the targeting range and precision of Cas9. Nat. Methods12, 1150–1156 (2015). ArticleCASPubMedPubMed Central Google Scholar
Sternberg, S. H., LaFrance, B., Kaplan, M. & Doudna, J. A. Conformational control of DNA target cleavage by CRISPR-Cas9. Nature527, 110–113 (2015). ArticleCASPubMedPubMed Central Google Scholar
Dahlman, J. E. et al. Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease. Nat. Biotechnol.33, 1159–1161 (2015). ArticleCASPubMedPubMed Central Google Scholar
Yang, L. et al. Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells. Nat. Commun.5, 5507 (2014). ArticleCASPubMed Google Scholar
Cencic, R. et al. Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage. PLoS ONE9, e109213 (2014). ArticlePubMedPubMed CentralCAS Google Scholar
O'Geen, H., Henry, I. M., Bhakta, M. S., Meckler, J. F. & Segal, D. J. A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture. Nucleic Acids Res.43, 3389–3404 (2015). ArticlePubMedPubMed CentralCAS Google Scholar